Importer of Controlled Substances Application: Sigma-Aldrich International GMBH, 35547-35548 [2017-16059]
Download as PDF
<![CDATA[
35547
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
SUPPLEMENTARY INFORMATION:
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
7, 2017, R & D Systems, Inc., BioTechne, 614 McKinley Place NE.,
Minneapolis, Minnesota 55413 applied
to be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
The company plans to import bulk
active pharmaceutical controlled
substances for distribution to its
customers for analytical purposes.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–16064 Filed 7–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sigma-Aldrich
International GMBH
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
sradovich on DSKBCFCHB2PROD with NOTICES
DATES:
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 30, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 30,
2017.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
ADDRESSES:
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
Aminorex ..........................................................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
17:38 Jul 28, 2017
Jkt 241001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix of subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on January
19, 2016, Sigma-Aldrich International
GMBH, Sigma Aldrich Co. LLC, 3500
Dekalb Street, Saint Louis, Missouri
63118 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
VerDate Sep<11>2014
1248
7118
7297
7360
7370
7391
7405
7435
7438
2270
7471
9041
Schedule
E:\FR\FM\31JYN1.SGM
31JYN1
1235
1237
1248
1475
1585
2010
Schedule
I
I
I
I
I
I
35548
Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices
Controlled substance
Drug code
Methaqualone ..................................................................................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Butylone ...........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Etonitazene ......................................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium, powdered ............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis.
[FR Doc. 2017–16059 Filed 7–28–17; 8:45 am]
The Department of Labor
published a document in the Federal
Register of July 25, 2017 (82 FR 34553),
concerning requests for nominations for
the task force on apprenticeship
expansion. The document contained an
incorrect email address in the FOR
FURTHER INFORMATION CONTACT section.
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
Employment and Training
Administration
sradovich on DSKBCFCHB2PROD with NOTICES
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
FOR FURTHER INFORMATION CONTACT:
Please contact Ms. Natalie S. Linton,
Program Analyst, Employment and
Training Administration, Office of
Apprenticeship, at Linton.Natalie.S@
dol.gov, telephone (202) 693–3592 (this
is not a toll-free number).
2565
7249
7260
7315
7360
7370
7381
7391
7392
7395
7396
7400
7402
7404
7405
7411
7433
7434
7435
7437
7438
7470
7493
7535
7541
9200
9313
9624
2125
2270
2315
2550
7379
7471
9170
9180
9190
9220
9230
9333
9639
9648
Schedule
Nominations for the Task Force on
Apprenticeship Expansion; Correction
Employment and Training
Administration, Labor.
AGENCY:
SUMMARY:
Correction
In the Federal Register of July 25,
2017, in FR Doc. 2017–15682, in the FOR
FURTHER INFORMATION CONTACT section
located in the third column of page
Solicitation of Nominations to
Serve on the Task Force on
Apprenticeship Expansion.
ACTION:
VerDate Sep<11>2014
17:38 Jul 28, 2017
Jkt 241001
PO 00000
34553, correct the email address to read:
Linton.Natalie.S@dol.gov.
Byron Zuidema,
Deputy Assistant Secretary for the
Employment and Training Administration.
[FR Doc. 2017–16062 Filed 7–28–17; 8:45 am]
BILLING CODE 4510–FR–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Electric
Power Generation, Transmission, and
Distribution Standard for Construction
and General Industry and Electrical
Protective Equipment for Construction
and General Industry
Notice of availability; request
for comments.
ACTION:
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Pages 35547-35548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16059]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Sigma-Aldrich
International GMBH
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before August 30, 2017. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before August 30, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix of subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co.
LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be
registered as an importer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone.......................... 1235 I
Methcathinone...................... 1237 I
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
N-Ethylamphetamine................. 1475 I
Aminorex........................... 1585 I
Gamma Hydroxybutyric Acid.......... 2010 I
[[Page 35548]]
Methaqualone....................... 2565 I
Alpha-ethyltryptamine.............. 7249 I
Ibogaine........................... 7260 I
Lysergic acid diethylamide......... 7315 I
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Mescaline.......................... 7381 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine.. 7395 I
2,5-Dimethoxyamphetamine........... 7396 I
3,4-Methylenedioxyamphetamine...... 7400 I
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine.. 7405 I
4-Methoxyamphetamine............... 7411 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocybin......................... 7437 I
Psilocyn........................... 7438 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine................. 7493 I
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
Butylone........................... 7541 I
Heroin............................. 9200 I
Normorphine........................ 9313 I
Etonitazene........................ 9624 I
Amobarbital........................ 2125 II
Pentobarbital...................... 2270 II
Secobarbital....................... 2315 II
Glutethimide....................... 2550 II
Nabilone........................... 7379 II
Phencyclidine...................... 7471 II
Diphenoxylate...................... 9170 II
Ecgonine........................... 9180 II
Ethylmorphine...................... 9190 II
Levorphanol........................ 9220 II
Meperidine......................... 9230 II
Thebaine........................... 9333 II
Opium, powdered.................... 9639 II
Levo-alphacetylmethadol............ 9648 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis.
Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-16059 Filed 7-28-17; 8:45 am]
BILLING CODE 4410-09-P
